180 Life Sciences Corp. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Loans Payable (Details)

Loans Payable (Details)										1 Months Ended	2 Months Ended	12 Months Ended
Loans Payable (Details)	Dec. 10, 2021 USD ($)	Sep. 30, 2021 USD ($) $ / shares shares	Aug. 05, 2021 USD ($)	May 19, 2021 USD ($)	Mar. 03, 2021 USD ($)	Feb. 10, 2021 USD ($)	Jun. 12, 2020	Jun. 10, 2020 USD ($)	Jun. 10, 2020 GBP (£)	May 19, 2021 USD ($)	May 31, 2020 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2021 GBP (£)	Dec. 31, 2020 USD ($)	Dec. 31, 2020 GBP (£)	Jun. 12, 2021 USD ($)
Loans Payable (Details) [Line Items]
Accrued interest					$ 12,452							$ 1,051	£ 778
Interest expense												135,953		$ 1,002,424
Loan forgiveness amount				$ 162,452
Financed in loans payable												1,618,443
Maximum loan amount (in Pounds) \| £									£ 50,000
Interest expense												1,051	£ 778
Maturity date							Aug. 31, 2021
Aggregate principal amount																$ 150,000
Interest percentage																15.00%
Aggregate principal amount					$ 150,000
Directors and officers insurance policy												655,593
Bounce back loan scheme												4,724
First assurance funding to finance	$ 1,618,443
Total D&O insurance amount	$ 2,005,502
Monthly installment loans												$ 161,844
Loans payable percentage												10.00%	10.00%
Principal amount						$ 432,699
Exchange an aggregate principal amount		$ 433,374
Aggregate accrued interest		$ 61,530
Aggregate shares (in Shares) \| shares		82,484
Common stock price (in Dollars per share) \| $ / shares		$ 6
Interest expense on loans payable, description.												For the year ended December 31, 2021, the Company recognized interest expense and interest expense — related parties associated with outstanding loans, of $24,019 and $38,874, respectively. For the year ended December 31, 2020, the Company recognized interest expense and interest expense — related parties associated with outstanding loans, of $23,709 and $35,973, respectively. As of December 31, 2021, the Company had accrued interest and accrued interest — related parties associated with outstanding loans, of $24,212 and $812, respectively. See Note 15 — Related Parties for additional details. As of December 31, 2020, the Company had accrued interest and accrued interest — related parties associated with outstanding loans, of $24,824 and $37,539, respectively. See Note 15 — Related Parties for additional details.	For the year ended December 31, 2021, the Company recognized interest expense and interest expense — related parties associated with outstanding loans, of $24,019 and $38,874, respectively. For the year ended December 31, 2020, the Company recognized interest expense and interest expense — related parties associated with outstanding loans, of $23,709 and $35,973, respectively. As of December 31, 2021, the Company had accrued interest and accrued interest — related parties associated with outstanding loans, of $24,212 and $812, respectively. See Note 15 — Related Parties for additional details. As of December 31, 2020, the Company had accrued interest and accrued interest — related parties associated with outstanding loans, of $24,824 and $37,539, respectively. See Note 15 — Related Parties for additional details.
PPP Loans [Member]
Loans Payable (Details) [Line Items]
Loan proceeds											$ 53,051
Interest percentage												1.00%
Accrued interest												$ 163		354
Interest expense												$ 1,636		354
Loan forgiveness amount			$ 9,670							$ 51,051
Financed in loans payable		$ 2,000
Bounce Back Loan Scheme [Member]
Loans Payable (Details) [Line Items]
Interest percentage									2.50%
Accrued interest														702	£ 514
Cash proceed								$ 64,353	£ 50,000
Interest expense														$ 702	£ 514